1-((1H-imidazol-2-yl)methyl)-6-(4-(1-aminocyclobutyl)phenyl)-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one → 2-(7-(4-(1-aminocyclobutyl)phenyl)-1-oxo-8-phenyl-1H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2(4H)-yl)acetonitrile

HRID 1509250Notes

Reaction equation

HRID 1509250 reaction equation
N1C=CN=C1CN1C(=O)COC2N=C(C3C=CC(C4(N)CCC4)=CC=3)C(C3C=CC=CC=3)=CC1=2.C(OC(=O)[NH:41][C:42]1([C:46]2[CH:51]=[CH:50][C:49]([C:52]3[C:53]([C:69]4[CH:74]=[CH:73][CH:72]=[CH:71][CH:70]=4)=[CH:54][C:55]4[N:60]5[C:61](=[O:67])[N:62]([CH2:64][C:65]#[N:66])[N:63]=[C:59]5[CH2:58][O:57][C:56]=4[N:68]=3)=[CH:48][CH:47]=2)[CH2:45][CH2:44][CH2:43]1)(C)(C)C>>[NH2:41][C:42]1([C:46]2[CH:51]=[CH:50][C:49]([C:52]3[C:53]([C:69]4[CH:70]=[CH:71][CH:72]=[CH:73][CH:74]=4)=[CH:54][C:55]4[N:60]5[C:61](=[O:67])[N:62]([CH2:64][C:65]#[N:66])[N:63]=[C:59]5[CH2:58][O:57][C:56]=4[N:68]=3)=[CH:48][CH:47]=2)[CH2:45][CH2:44][CH2:43]1

Participants

3

Reactant 2

HCID 532620541-((1H-imidazol-2-yl)methyl)-6-(4-(1-aminocyclobutyl)phenyl)-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-oneHCID 123592920HCID 123592920, compound

Product 1

HCID 532625112-(7-(4-(1-aminocyclobutyl)phenyl)-1-oxo-8-phenyl-1H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2(4H)-yl)acetonitrileYield 94.3%

Procedure

Following the procedure for 1-((1H-imidazol-2-yl)methyl)-6-(4-(1-aminocyclobutyl)phenyl)-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, tert-butyl(1-(4-(2-(cyanomethyl)-1-oxo-8-phenyl-2,4-dihydro-1H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazin-7-yl)phenyl)cyclobutyl)carbamate (45 mg, 0.08 mmol) was reacted to afford the title compound (34 mg, 61%). LCMS (Method D): RT=0.777 min, M-NH2=434. 1H NMR (500 MHz, MeOD): 8.54 (1H, s), 7.45 (2H, d), 7.41 (2H, d), 7.33-7.31 (3H, m), 7.24-7.23 (m, 2H), 5.47 (2H, s), 5.01 (2H, s), 2.78-2.72 (m, 2H), 2.59-2.53 (m, 2H), 2.25-2.18 (m, 1H), 1.99-1.91 (m, 1H).

Workup

  1. customwas reacted

Sources & evidence

ORD record
ord-feb34c669070439a819a87b2b4c3d38f
Source dataset
uspto-grants-2015_12
Patent number
US09221838B2

Reaction notes

Loading…